Related Experiment Video
Updated: Oct 14, 2025
07:59
A Comprehensive Procedure to Evaluate the In Vivo Performance of Cancer Nanomedicines
Published on: March 4, 2017
9.1K
Cancer nanotechnology: current status and perspectives.
Jessica A Kemp1, Young Jik Kwon2,3,4,5
1Department of Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, 92697, USA.
Nano Convergence
|November 2, 2021
Summary
Nanotechnology offers advanced solutions for cancer care, improving drug delivery, early detection, and imaging. These nanomaterials enhance treatment specificity and reduce side effects, marking a significant step forward in oncology.
Area of Science:
- Oncology
- Nanotechnology
- Biomedical Engineering
Background:
- Cancer treatment faces challenges with specificity and systemic toxicity.
- Early cancer diagnosis is crucial for improving patient outcomes.
- Nanotechnology presents a transformative approach to cancer care.
Purpose of the Study:
- To review current clinical and pre-clinical applications of nanotechnology in cancer.
- To highlight nanotechnological advancements in drug therapy, diagnostics, imaging, and radiotherapy.
Main Methods:
- Review of existing literature on nanotechnological applications in oncology.
- Analysis of nanomedicine's role in targeted cancer therapy, diagnostics, and imaging.
Main Results:
- Nanomaterials demonstrate versatility for targeted drug delivery and enhanced radiotherapy.
- Nanotechnology enables development of accurate early-detection devices and robust imaging modalities.
- Significant progress in nanomedicine for augmenting cancer chemotherapy and radiotherapy.
Conclusions:
- Nanotechnology is revolutionizing cancer diagnostics and therapeutics.
- Nanomaterials offer enhanced specificity and reduced toxicity in cancer treatment.
- Further integration of nanotechnology promises improved patient care and prognosis in oncology.
Related Concept Videos
02:57Targeted Cancer Therapies
7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.9K
02:49Cancer Therapies
8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K
02:07Tumor Progression
6.6K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.6K
01:21Cancer Survival Analysis
478
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
478
01:30Cancer Vaccines
562
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
562
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K